biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by BigDolphinon Feb 24, 2017 9:40pm

104 Views

Post# 25892365

RE:RE:RE:RE:RE:RE:When will Rob do another interview at a restaurant?

Hey !!!! How u know more than others?! That wouldn't be fair now would it?! Ooooohhhhh you must have insider knowledge I am guessing? Or am I missing something? Cuz this is all public companies. Nobody knows more than the next guy right?! Care to esplain? Yes that's spelt wrong so is that. JD. You don't need the money buddy. Cmoooooooonnnnnnnnnn. Pleeaeeeaaaaaaaaasssseeeeeeee let us in on what u know puleaaaaasssssseeeeeee??!!!!

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta